Regulus Therapeutics (RGLS) Stock: Falling On Double Dose Of Bad News

Regulus Therapeutics Inc (NASDAQ: RGLS) Regulus Therapeutics is having a rough day in the market today, and for good reason. There was a double whammy of bad news released with regard to the company that’s causing the declines. Today, we’ll talk about the news, what we’re seeing from the stock, and what we can expect … Read more

Morning Buzz: Clean Diesel (CDTI), AVEO Pharmaceuticals (AVEO), Youku Tudou (YOKU), Regulus Therapeutics (RGLS)

Shares of Clean Diesel Technologies Inc. (CDTI) are higher by nearly 20% to $2.45 in pre-market trading on Tuesday after the company reported compelling vehicle test results for Spinel(TM) technology, its proprietary clean emissions exhaust technology that is expected to dramatically reduce the cost for auto manufacturers to attain increasingly stringent clean air standards. “These … Read more

Biotech News- 2/9/15 to 2/13/15

Achillion Pharmaceuticals (ACHN) Shares of Achillion gained 7% on 2/9/15 last week when it had announced that it had achieved a 100% SVR12 in a phase 2 trial treating patients with the genotype 1 version of the Hepatitis C virus — HCV. The trial tested for the primary objective of patients being able to achieve a … Read more